Javascript must be enabled to continue!
Antibodies against hepatitis E virus in old world monkeys
View through CrossRef
SUMMARY. To examine whether Indian monkeys are infected with hepatitis E virus (HEV) in nature, serum samples from wild rhesus (Macaca mullata), bonnet (M. radiata) and langur (Presbytes entellus) monkeys were screened for anti‐HEV IgG antibodies in recombinant antigen‐based ELISA assays. The positivity rates were 36.7%. 19.1% and 2% respectively. The protection of such antibodies against human HEV was studied in four rhesus monkeys. Of the two rhesus monkeys with anti‐HEV titres of 100 and 1000 respectively which were inoculated with the KOL‐91 strain of HEV, the former demonstrated a 10‐fold rise in anti‐HEV titres. Anti‐HEV titre in the second rhesus monkey remained unchanged. Neither of the monkeys showed any rise in serum alanine transaminase (ALT) or presence of virus in the faeces, as tested by polymerase chain reaction (PCR). Two other rhesus monkeys with anti‐HEV titres of 10000 and 100 respectively were inoculated with the AKL‐90 strain of HEV. Serum ALT levels and anti‐HEV titres remained unchanged in the first monkey. Excretion of virus in faeces was not noted (PCR). The second monkey developed a typical HEV infection. HEV infection could be produced in anti‐HEV negative control monkeys inoculated with both strains of HEV. These results show that either human or simian HEV, or a closely related agent, is circulating among Indian macaques. Titre‐dependent protection of naturally occurring anti‐HEV antibodies supports this view.
Title: Antibodies against hepatitis E virus in old world monkeys
Description:
SUMMARY.
To examine whether Indian monkeys are infected with hepatitis E virus (HEV) in nature, serum samples from wild rhesus (Macaca mullata), bonnet (M.
radiata) and langur (Presbytes entellus) monkeys were screened for anti‐HEV IgG antibodies in recombinant antigen‐based ELISA assays.
The positivity rates were 36.
7%.
19.
1% and 2% respectively.
The protection of such antibodies against human HEV was studied in four rhesus monkeys.
Of the two rhesus monkeys with anti‐HEV titres of 100 and 1000 respectively which were inoculated with the KOL‐91 strain of HEV, the former demonstrated a 10‐fold rise in anti‐HEV titres.
Anti‐HEV titre in the second rhesus monkey remained unchanged.
Neither of the monkeys showed any rise in serum alanine transaminase (ALT) or presence of virus in the faeces, as tested by polymerase chain reaction (PCR).
Two other rhesus monkeys with anti‐HEV titres of 10000 and 100 respectively were inoculated with the AKL‐90 strain of HEV.
Serum ALT levels and anti‐HEV titres remained unchanged in the first monkey.
Excretion of virus in faeces was not noted (PCR).
The second monkey developed a typical HEV infection.
HEV infection could be produced in anti‐HEV negative control monkeys inoculated with both strains of HEV.
These results show that either human or simian HEV, or a closely related agent, is circulating among Indian macaques.
Titre‐dependent protection of naturally occurring anti‐HEV antibodies supports this view.
Related Results
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
To assess possible role of testing for IgM-specific antibody in the diagnosis and monitoring of patients with hepatitis C, we tested sera from 14 patients with acute and 97 patient...
Interactions Between Human Immunodeficiency Virus–1, Hepatitis Delta Virus and Hepatitis B Virus Infections in 260 Chronic Carriers of Hepatitis B Virus
Interactions Between Human Immunodeficiency Virus–1, Hepatitis Delta Virus and Hepatitis B Virus Infections in 260 Chronic Carriers of Hepatitis B Virus
To evaluate the factors determining the severity of chronic hepatitis B virus infection and the interactions of human immunodeficiency virus and hepatitis delta virus infections, w...
Prevalence of Hepatitis C Virus Infection in Hemodialysis Patients: A Longitudinal Study Comparing the Results of RNA and Antibody Assays
Prevalence of Hepatitis C Virus Infection in Hemodialysis Patients: A Longitudinal Study Comparing the Results of RNA and Antibody Assays
We longitudinally studied 51 patients from two hemodialysis centers to determine the prevalence of hepatitis C virus infection in hemodialysis patients. Serum samples were tested f...
Changes in Hepatitis C Awareness in Different Disciplines During COVID-19
Changes in Hepatitis C Awareness in Different Disciplines During COVID-19
Background: We aimed to determine the awareness of referring hepatitis C virus patients to the relevant departments and the effect of the pandemic period on this subject. Methods: ...
Association of poor virus specific immunoglobulin G antibody responses with higher viral load is seen in Bangladeshi pregnant women having acute Hepatitis E Genotype 1 infection
Association of poor virus specific immunoglobulin G antibody responses with higher viral load is seen in Bangladeshi pregnant women having acute Hepatitis E Genotype 1 infection
Abstract
Although Hepatitis E viral illness is usually self-limiting, higher rates of morbidity and mortality are frequently observed during pregnancy in South Asia...
Seroprevalence and clinical outcome of hepatitis D infection in Qatar
Seroprevalence and clinical outcome of hepatitis D infection in Qatar
Background: Worldwide, 5–10% of people with chronic hepatitis B virus infection are co-infected with hepatitis D virus. In Qatar, there are no data on hepatitis D virus infection a...

